Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Ocular Safety of Calcium Formate in Normal, Healthy Female Subjects

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy females~Exclusion Criteria:~* no ocular diseases

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Open label (Type: EXPERIMENTAL): Each participant will be treated with three 3900 mg doses of calcium formate on each study day (i.e., days 1-14).

Based on this trial design, predict the completion outcome and termination type (if applicable).